Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Zoetis is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-08Current report (material event)
- 8-K2026-08-06Current report (material event)
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-06Current report (material event)
- SCHEDULE 13G/A2026-07-30SCHEDULE 13G/A
- 11-K2026-06-2211-K
- SD2026-05-28SD
- 8-K2026-05-22Current report (material event)
- 8-K2026-05-20Current report (material event)
- 10-Q2026-05-07Quarterly report
- 8-K2026-05-07Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- ARS2026-04-08Annual report to holders
- DEFA14A2026-04-08DEFA14A
- DEF 14A2026-04-08Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-02-12Annual report
- 8-K2026-02-12Current report (material event)
- 8-K2026-02-05Current report (material event)
- SCHEDULE 13G/A2026-01-07SCHEDULE 13G/A
- 8-K2025-12-18Current report (material event)
- 8-K2025-12-11Current report (material event)
- 8-K2025-12-02Current report (material event)
- 10-Q2025-11-04Quarterly report
- 8-K2025-11-04Current report (material event)
- 8-K2025-10-28Current report (material event)
- 8-K2025-10-09Current report (material event)
- 8-K2025-08-27Current report (material event)
- 8-K2025-08-18Current report (material event)
- 424B32025-08-12424B3
- FWP2025-08-11FWP
- 424B32025-08-11424B3
- S-3ASR2025-08-05S-3ASR
- 10-Q2025-08-05Quarterly report
- 8-K2025-08-05Current report (material event)
- 11-K2025-06-2311-K
- SD2025-06-02SD
- 8-K2025-05-22Current report (material event)
- 8-K2025-05-21Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.